Lipid Accumulation in Peripheral Blood Dendritic Cells and Anticancer Immunity in Patients with Lung Cancer

Figure 5

BODIPY 650/665 fluorescence intensity in mDC and pDC. This figure shows the percentages of HLA-DR(+), Lineage(−) DCs, and BODIPY-positive mDCs and pDCs. Significantly, more mDCs were observed in stage I + II and stage III + IV lung cancer patients than in the controls.